MedPath

Using Boot Camp Translation to Address Rural Disparities in Adolescent Vaccination

Not Applicable
Conditions
Primary Prevention
Interventions
Behavioral: Boot Camp Translation
Other: Control
Registration Number
NCT03955757
Lead Sponsor
University of Colorado, Denver
Brief Summary

The overall goal of this project is to implement the Boot Camp Translation process to develop a replicable approach for increasing adolescent vaccine uptake that can be adaptable and feasible to use in rural settings more broadly.

Detailed Description

Boot Camp Translation (BCT) is a process to identify strategies that help communities improve health. It is a 6-month, facilitated, iterative community engagement process that brings together relevant stakeholders to develop and implement locally meaningful messages, materials, and strategies for health topics of interest.

This is a novel community engagement process that has a proven ability to result in meaningful and impactful strategies to improve compliance with recommended health behaviors in rural communities. The investigators will expand this work by testing BCT on its ability to improve vaccination with all recommend adolescent vaccines (Tdap, MenACWY, HPV, Flu).

The investigators will conduct a randomized, controlled trial in which 4 rural communities in Western Colorado will undergo BCT to develop and implement strategies to increase adolescent vaccination. Vaccination rates will be compared to 4 control communities that do not undergo BCT.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
6000
Inclusion Criteria
  • Must live in one of the designated Colorado communities
Exclusion Criteria
  • Does not live in one of the designated Colorado communities

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Boot Camp TranslationBoot Camp TranslationIntervention communities will undergo the Boot Camp Translation process.
ControlControlControl communities will behave as usual
Primary Outcome Measures
NameTimeMethod
Initiation of HPV vaccination series, 11-12 year oldsUp to 24 months

Percent of 11-12 year olds who have received \>=1 dose of the HPV vaccine by May 31,2021

Secondary Outcome Measures
NameTimeMethod
Completion of HPV vaccination series, 11-12 year oldsUp to 24 months

Percent of 11-12 year olds with \>=2 doses of the HPV vaccine by May 31,2021

Initiation of HPV vaccination series, 13-17 year oldsUp to 24 months

Percent of 13-17 year olds who have received \>=1 dose of the HPV vaccine by May 31,2021

Completion of HPV vaccination series, 13-17 year oldsUp to 24 months

Percent of 13-17 year olds who have completed the HPV vaccine series (2 or 3 doses, depending on age of initiation) by May 31,2021

Receipt of Tdap vaccine, 11-12 year oldsUp to 24 months

Percent of 11-12 year olds who have received Tdap vaccine by May 31,2021

Receipt of Tdap vaccine, 13-17 year oldsUp to 24 months

Percent of 13-17 year olds who have received Tdap vaccine by May 31,2021

Receipt of MCV vaccine, 11-12 year oldsUp to 24 months

Percent of 11-12 year olds who have received \>=1 dose of MCV vaccine by May 31,2021

Receipt of MCV vaccine, 13-17 year oldsUp to 24 months

Percent of 13-17 year olds who have received \>=1 dose of MCV vaccine by May 31,2021

Trial Locations

Locations (1)

University of Colorado Anschutz Medical Campus

🇺🇸

Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath